The emerging treatment landscape in ATTR amyloidosis: what’s on the horizon?
Topic:
Chronic Heart Failure, Other
Speaker:
Professor C. Rapezzi (Ferrara, IT)
Organised by Medscape Education, supported by independent educational grants from Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., and Eidos Therapeutics, Inc.
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Claudio Rapezzi
University of Ferrara, Ferrara (Italy)
29
presentations
1
follower
4 more presentations in this session
Welcome and introduction - Amyloidosis beyond heart failure: paving the way for an early diagnosis.
Speaker: Doctor M. Grogan (Rochester, US)
Delayed diagnosis of amyloidosis: what if the patient does not have heart failure?
Speaker: Doctor M. Grogan (Rochester, US)
Managing amyloidosis in cardiology practice: a call for collaboration.
Speaker: Doctor M. Maurer (New York, US)
Panel discussion and question and answer session - Amyloidosis beyond heart failure: paving the way for an early diagnosis.
Speaker: Doctor M. Grogan (Rochester, US)
Access the full session
Amyloidosis beyond heart failure: paving the way for an early diagnosis
Speakers:
Professor C. Rapezzi, Doctor M. Grogan, Doctor M. Grogan, Doctor M. Maurer, Doctor M. Grogan
About the event
ESC 365 is supported by
